Ingeborg J. H. Vriens

Author

Also Known As

I Vriens, I. J. H. (Ingeborg) Vriens, I. J. H. Vriens, I. Vriens, I.J.H. Vriens, Ingeborg J H Vriens, Ingeborg J Vriens, Ingeborg J. H. Vriens, Ingeborg J.H. Vriens, Ingeborg Vriens

Publications

476

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen The Netherlands Cancer Institute Catharina Ziekenhuis Leiden University Medical Center Netherlands Comprehensive Cancer Organisation

About

Ingeborg J. H. Vriens is an author at Radboud University Nijmegen specializing in breast cancer, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	38
2	Obstetrics	2	2	27
3	Endocrinology	1	1	14
4	Pharmacology	1	1	14
5	Surgical Oncology	1	1	11

Ingeborg J. H. Vriens

Publications

352

Citations

H-Index

Page 1

	Year	Citations
Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers Marc B. I. Lobbes, Ingeborg J. H. Vriens, A.C.M. van Bommel, Breast Cancer Research and Treatment	2017	71
Counseling young women with early breast cancer on fertility preservation M Elena ter Welle-Butalid, Ingeborg J. H. Vriens, Josien G. Derhaag, Journal of Assisted Reproduction and Genetics	2019	51
Patient and diagnostic intervals of survivors of sarcoma: Results from the SURVSARC study Vicky L. M. N. Soomers, Olga Husson, Ingrid M.E. Desar, Cancer	2020	32
Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure Irene E.G. van Hellemond, Ingeborg J. H. Vriens, Petronella G.M. Peer, JNCI Journal of the National Cancer Institute	2017	31
Unraveling the Heterogeneity of Sarcoma Survivors’ Health-Related Quality of Life Regarding Primary Sarcoma Location: Results from the SURVSARC Study Ilse van Eck, Dide den Hollander, Ingrid M.E. Desar, Cancers	2020	29
The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients Ingeborg J. H. Vriens, Ashley J.R. De Bie, Maureen J.B. Aarts, Oncotarget	2017	26
Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer Birgit E. P. J. Vriens, Ingeborg J. H. Vriens, Maureen J.B. Aarts, Breast Cancer Research and Treatment	2017	17
Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial Vivianne C. G. Tjan‐Heijnen, S W M Lammers, Sandra M. E. Geurts, EClinicalMedicine Endocrine OncologyBreast OncologyMedicinePharmacologyData Trial	2023	14
Ten-year experience of a national multidisciplinary tumour board for cancer and pregnancy in the Netherlands Joosje H. Heimovaara, Ingrid Boere, J. de Haan, European Journal of Cancer MedicineCancer ManagementEpidemiology Of CancerGynecologyCancer Registration	2022	13
The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial S W M Lammers, Sandra M. E. Geurts, Karlijn Susanna Francisca Maria Hermans, ESMO Open	2025	13

Page 1